APA (7th ed.) Citation

EJ, G., GBE, J., EP, P., NC, R., I, O., J, W., . . . CJ, S. (2026). Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: Results of the SHINE double-blind placebo-controlled randomized trial. The British journal of dermatology, 194(2), 254. https://doi.org/10.1093/bjd/ljaf398

Chicago Style (17th ed.) Citation

EJ, Giamarellos-Bourboulis, et al. "Vilobelimab to Improve Clinical Outcomes in Moderate-to-severe Hidradenitis Suppurativa Through an Adjunctive Effect on Draining Tunnels: Results of the SHINE Double-blind Placebo-controlled Randomized Trial." The British Journal of Dermatology 194, no. 2 (2026): 254. https://doi.org/10.1093/bjd/ljaf398.

MLA (9th ed.) Citation

EJ, Giamarellos-Bourboulis, et al. "Vilobelimab to Improve Clinical Outcomes in Moderate-to-severe Hidradenitis Suppurativa Through an Adjunctive Effect on Draining Tunnels: Results of the SHINE Double-blind Placebo-controlled Randomized Trial." The British Journal of Dermatology, vol. 194, no. 2, 2026, p. 254, https://doi.org/10.1093/bjd/ljaf398.